Current through Register Vol. 48, No. 12, March 22, 2024
a) The
Department shall provide written application instructions and forms to
potential applicants.
b) The
Department will request a letter of intent from prospective applicants
approximately one month before applications are due. A letter of intent is not
binding on the prospective applicant. A letter of intent shall include the
descriptive title of the proposed research; the name, address and telephone
number of the principal investigator; the names of other key personnel; the
names of participating institutions; and, if applicable, the type of grant for
which the application is being submitted.
c) All applications shall include the
following:
1) The name, address and telephone,
FAX and teletypewriter (TTY) numbers, if available, of the institution applying
for the grant.
2) The principal
investigator's name, address and telephone, FAX and TTY numbers, if
available.
3) The curriculum vitae
of the principal investigator or principal investigators.
4) A one-page nontechnical abstract that
describes the significance of the applicant's project for stem cell
research.
5) The applicant's TIN or
the Governmental Unit Code assigned by the Illinois Comptroller.
6) The signature of the principal
investigator and agency official authorized to certify the
application.
7) An approximate
timetable for project expenditures and completion.
8) Background data and information justifying
the project.
9) A detailed budget
for the project period, documenting sufficient resources to carry out the
project. The budget shall be by line item category and shall provide sufficient
detail to justify the use of grant funds to support project activities. The
applicant shall indicate the total cost of conducting the project; the
anticipated funding request for each year of the project period; the source of
other funds in hand supporting the research project; other grants or funds
awarded, denied or pending; and the amount of support requested from the
Department.
10) A Statement of
Assurances, signed by a responsible official, indicating compliance with
applicable State and federal requirements.
11) A statement of the type of grant being
requested (see Section
995.60(a)
).
12) A statement of the research question or
hypothesis or a description of interventions or model programs on which the
research will be based.
13) A
prioritized listing of measurable objectives for the project period.
14) Proposed activities for experiments,
scientific rationale and relevant reference to existing works.
15) The evaluation methods to be used to
measure progress in achieving objectives and a plan for monitoring the overall
project.
16) A sample informed
consent document (with patient identifier information removed) and a
description of the informed consent process that meets the criteria for
informed consent set forth in this Part (see Section
995.90(e)
).
17) The written guidelines under which the
research will proceed and documentation of approval from the IRB, and, if the
grant activities require, from the ESCRO committee and IACUC.
